Sinapultide

N/A

Report date: 2023/05/22 13:57:05
NMEFirst In Class

Base Information

Drug NameSinapultide
Drug Alias Name西那普肽sinapultidaAerosolized KL4 surfactantKL4 pulmonary surfactantKL-4 lung surfactant +[18] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCell membrane permeability enhancers
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, NewbornRespiratory Distress Syndrome, Adult
Global Approved IndicationsRespiratory Distress Syndrome, NewbornRespiratory Distress Syndrome, Adult
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/03/06
Country/TerritoryUnited StatesPolandArgentina
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesWindtree Therapeutics Inc
Inactive CompaniesLee'S Pharmaceutical (Hk) Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Inactive IndicationsRespiratory Distress Syndrome, Newborn

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG